Vasopressin-2 receptor blockers: mechanism of action and clinical utility - Q. Qian
medcases00
Published on Aug 18, 2021
Video Embed -original source - RRIV International Renal Research Institute Vicenza
https://www.youtube.com/c/IRRIVInternationalRenalResearchInstituteVicenza/videos
Category
Add to
Please Sign In or Create Account to use this feature!
Flag Video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Up next
Autoplay
Autoplay
Recommended
-
Watch Later
01:02:44Exploring the Science and Practice of GLP-1 Receptor Agonists
234 views 1587 days ago -
Watch Later
31:29Ian de Boer, MD, MS - GLP-1 Receptor Agonists for Patient with Kidney Disease
520 views 1293 days ago -
Watch Later
52:06Clinical & Diagnostic Features of Bartter and Gitelman Syndromes
198 views 1339 days ago -
Watch Later
![MCD vs. FSGS: Breakdown of Diagnostics and Clinical Course]()
01:05:18MCD vs. FSGS: Breakdown of Diagnostics and Clinical Course
263 views 1292 days ago -
Watch Later
![KDIGO Clinical Practice Guideline on Diabetes Management in CKD]()
29:08KDIGO Clinical Practice Guideline on Diabetes Management in CKD
311 views 1578 days ago
